StockData
Immunic, Inc. logo

Immunic, Inc. (IMUX) stock

IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$7.39−0.13 (-1.73%)

Close on Nov 19, 2026Market cap $100.83MP/E –Yield 0.00%

Immunic shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Immunic's shares outstanding was 43M at Jun 30, 2026. For fiscal 2025 it was 16M, up 55.4% from the year before. Over ten years it grew 77.4% a year on average. The highest annual figure on record is 16M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202516M+55.4%
FY2024Dec 31, 202410M+126.0%
FY2023Dec 31, 20234M+39.3%
FY2022Dec 31, 20223M+34.5%
FY2021Dec 31, 20212M+51.0%
FY2020Dec 31, 20202M+102.8%
FY2019Dec 31, 20191M+811.8%
FY2018Dec 31, 20180M+6.2%
FY2017Dec 31, 20170M+27.0%
FY2016Dec 31, 20160M+24.8%
FY2015Dec 31, 20150M+56.7%
FY2014Dec 31, 20140M+2975.6%
FY2013Dec 31, 20130M+22.2%
FY2012Dec 31, 20120M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202643M+221.6%
Q1 FY2026Mar 31, 202630M+197.4%
Q4 FY2025Dec 31, 202519M+93.0%
Q3 FY2025Sep 30, 202519M+91.5%
Q2 FY2025Jun 30, 202513M+30.5%
Q1 FY2025Mar 31, 202510M+4.2%
Q4 FY2024Dec 31, 202410M+125.8%
Q3 FY2024Sep 30, 202410M+127.2%
Q2 FY2024Jun 30, 202410M+127.9%
Q1 FY2024Mar 31, 202410M+122.8%
Q4 FY2023Dec 31, 20234M+16.4%
Q3 FY2023Sep 30, 20234M+45.8%
Q2 FY2023Jun 30, 20234M+46.9%
Q1 FY2023Mar 31, 20234M+55.2%
Q4 FY2022Dec 31, 20224M+28.0%
Q3 FY2022Sep 30, 20223M+20.7%
Q2 FY2022Jun 30, 20223M+39.1%
Q1 FY2022Mar 31, 20223M+32.8%
Q4 FY2021Dec 31, 20213M+44.2%
Q3 FY2021Sep 30, 20213M+37.6%
Q2 FY2021Jun 30, 20212M+71.3%
Q1 FY2021Mar 31, 20212M+97.0%
Q4 FY2020Dec 31, 20202M+102.5%
Q3 FY2020Sep 30, 20202M+83.6%
Q2 FY2020Jun 30, 20201M+31.3%
Q1 FY2020Mar 31, 20201M+1169.2%
Q4 FY2019Dec 31, 20191M+1110.1%
Q3 FY2019Sep 30, 20191M+1083.4%
Q2 FY2019Jun 30, 20191M+1041.6%
Q1 FY2019Mar 31, 20190M-0.1%
Q4 FY2018Dec 31, 20180M+0.2%
Q3 FY2018Sep 30, 20180M+0.3%
Q2 FY2018Jun 30, 20180M+0.3%
Q1 FY2018Mar 31, 20180M+29.8%
Q4 FY2017Dec 31, 20170M+31.7%
Q3 FY2017Sep 30, 20170M+33.4%
Q2 FY2017Jun 30, 20170M–
Q1 FY2017Mar 31, 20170M–
Q4 FY2016Dec 31, 20160M–
Q3 FY2016Sep 30, 20160M–

More Immunic figures

See a number that looks wrong?